Clinical Trial Update: Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the clinical value of adding dapagliflozin in patients with nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Ain Shams University | Conditions: Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors | Phase 4 | Status: COMPLETED